Ventricular Assist Devices Market Share, Trend, Segmentation and Forecast to 2027

The report titled “Ventricular Assist Devices Market: Global Demand Analysis & Opportunity Outlook 2027” delivers the detailed overview of the global ventricular assist devices market in terms of market segmentation by product type, by application, by age, by design and by region.    

The global ventricular assist devices market is segmented on the basis of product type, application, age, design and region. The product type is further segmented intoright ventricular assist device (RVAD), left ventricular assist device (LVAD), biventricular assist device (BIVAD), percutaneous ventricular assist device (PVAD) & total artificial heart, out of which, the left ventricular assist deviceis expected to lead the product type segment on account of enhancement in the number of people suffering from end stage heart failure. On the basis of application, the market is sub-segmented into destination therapy, bridge-to-transplant therapy, bridge-to-candidacy therapy & bridge-to-recovery therapy.Based on age, the market is divided into the age group of – below 18, 19-39, 40-59, 60-79 & above 80. The market is segmented by design into implantable ventricular assist device & transcutaneous ventricular assist device. The ventricular assist devices industries across the globe are focusing on effectively increasing the life expectancy of the patients suffering from cardiovascular diseases which is anticipated to be the major reasonbehind the growth of the marketin upcoming years.

The global ventricular assist devices market is anticipated to expand at a CAGR of around 11% during the forecast period i.e. 2019-2027. Increasing cases of heart failure coupled with rising incidence of people suffering from cardiovascular diseases are the major reasons thatare anticipated to drive the growth of the market. Additionally, rising technological advancements pertaining to ventricular assist devices and rise in the geriatric population are some of the factors which are expected to support the growth of the market over the forecast period.

Request Sample of This Strategic Report @

Geographically, theglobal ventricular assist devices market is segmented into North America, Asia-Pacific, Latin America, Europe, Middle East and Africa, out of which, North America is anticipated to have the largest market share on account of rising incidence of cardiovascular diseases, increasing technological advancements and growing popularity pertaining to ventricular assist devices across the region.

Europe is anticipated to be a lucrative region for the market on account of rising geriatric population coupled with increasing prevalence of heart failure around the Europe region. Further, the Asia Pacific region is anticipated to showcase a high market growth in the global ventricular assist devices market on the back of growing mortality rate due to increased prevalence of cardiovascular diseases in the region.

Increasing Incidence of Cardiovascular Diseases to Boost Market Growth

The rising incidence of cardiovascular diseases such as stroke and myocardial infraction among others are expected to boost the growth of the market. On the other hand, growing rate of the geriatric population having a higher susceptibility to cardiovascular diseases is anticipated to boost the market revenue over the forecast period.

Request For COVID-19 Impact Insights on This Report@

About Research Nester

Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision so as to avoid future uncertainties.

Contact Us

AJ Daniel
U.S. Phone: [+1 646 586 9123]
U.K. Phone: [+44 203 608 591]